| EP1636185 - NOVEL CRYSTALLINE FORMS OF PERINDOPRIL ERBUMINE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 16.11.2012 Database last updated on 08.04.2026 | Most recent event Tooltip | 16.07.2021 | Change - lapse in a contracting state | published on 18.08.2021 [2021/33] | Applicant(s) | For all designated states Les Laboratoires Servier 35, rue de Verdun 92284 Suresnes Cedex / FR | [2012/24] |
| Former [2007/25] | For all designated states Les Laboratoires Servier 22, rue Garnier 92278 Neuilly sur Seine / FR | ||
| Former [2006/12] | For all designated states Azad Pharmaceutical Ingredients AG Friedbergstrasse 68 8200 Schaffhausen / CH | Inventor(s) | 01 /
STRÄSSLER, Christoph Unterfeldstrasse 17 CH-8050 Zürich / CH | 02 /
LELLEK, Vit Schauenbergstr. 8 CH-8046 Zürich / CH | 03 /
FÄSSLER, Roger Spitzacker 8 CH-8246 Langwiesen / CH | [2006/12] | Representative(s) | Braun, André jr., et al Braunpat Braun Eder AG Reussstrasse 22 Postfach 4015 Basel / CH | [N/P] |
| Former [2009/31] | Braun, André jr., et al Braunpat Braun Eder AG Reussstrasse 22 Postfach 4015 Basel / CH | ||
| Former [2006/12] | Braun, André jr., et al Braunpat Braun Eder AG Reussstrasse 22 4054 Basel / CH | Application number, filing date | 04737029.1 | 18.06.2004 | [2006/12] | WO2004CH00374 | Priority number, date | CH110903 | 24.06.2003 Original published format: CH 110903 | [2006/12] | Filing language | DE | Procedural language | DE | Publication | Type: | A1 Application with search report | No.: | WO2004113293 | Date: | 29.12.2004 | Language: | DE | [2004/53] | Type: | A1 Application with search report | No.: | EP1636185 | Date: | 22.03.2006 | Language: | DE | The application published by WIPO in one of the EPO official languages on 29.12.2004 takes the place of the publication of the European patent application. | [2006/12] | Type: | B1 Patent specification | No.: | EP1636185 | Date: | 11.01.2012 | Language: | DE | [2012/02] | Search report(s) | International search report - published on: | EP | 29.12.2004 | Classification | IPC: | C07D209/42 | [2006/12] | CPC: |
C07D209/42 (EP,KR,US);
A61K31/404 (KR);
A61P43/00 (EP);
A61P9/00 (EP);
A61P9/04 (EP);
A61P9/10 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/12] | Extension states | AL | 06.12.2005 | HR | 06.12.2005 | LT | 06.12.2005 | LV | 06.12.2005 | MK | 06.12.2005 | Title | German: | NEUE KRISTALLINE FORMEN VON PERINDOPRIL ERBUMINE | [2006/12] | English: | NOVEL CRYSTALLINE FORMS OF PERINDOPRIL ERBUMINE | [2006/12] | French: | NOUVELLES FORMES CRISTALLINES DE PERINDOPRIL ERBUMINE | [2006/12] | Entry into regional phase | 06.12.2005 | National basic fee paid | 06.12.2005 | Designation fee(s) paid | 06.12.2005 | Examination fee paid | Examination procedure | 06.12.2005 | Examination requested [2006/12] | 25.03.2008 | Despatch of a communication from the examining division (Time limit: M06) | 18.09.2008 | Reply to a communication from the examining division | 01.07.2011 | Date of oral proceedings | 12.07.2011 | Minutes of oral proceedings despatched | 28.07.2011 | Communication of intention to grant the patent | 09.11.2011 | Fee for grant paid | 09.11.2011 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 25.03.2008 | Opposition(s) | 12.10.2012 | No opposition filed within time limit [2012/51] | Fees paid | Renewal fee | 06.12.2005 | Renewal fee patent year 03 | 14.06.2007 | Renewal fee patent year 04 | 28.03.2008 | Renewal fee patent year 05 | 04.01.2010 | Renewal fee patent year 06 | 30.06.2010 | Renewal fee patent year 07 | 30.06.2011 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 30.06.2009 | 06   M06   Fee paid on   04.01.2010 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | TR | 18.06.2012 | [2021/33] |
| Former [2017/52] | TR | 18.06.2012 | |
| Former [2014/12] | TR | 18.06.2012 | |
| HU | 19.06.2012 | ||
| Former [2013/22] | HU | 19.06.2012 | |